(Received for publication August 10, 2001) CJ-15,696 and 7 novel furopyridine antibiotics were isolated from the fungus Cladobotryum varium CL 12284. Their structures were determined by X-ray crystallography and spectral analysis. Three biotransformed analogs were also prepared from CJ-15,696. CJ-15,696 showed moderate activity against various Gram-positive bacteria including some drug resistant strains such as methicillin resistant Staphylococcus aureus (MRSA).
There has been an alarming increase, recently, in the incidence of drug resistant infections that is limiting the utility of many standard agents1). For example, MRSA and vancomycin-resistant Enterococcus species are now co-resistant to essentially all other antibiotic classes2-4).
Streptococcus pneumoniae, a frequent cause of upper and lower respiratory tract infections in both children and adults is rapidly becoming resistant to all presently available lactams and the current macrolides are no longer reliably effective against such multidrug-resistant bacteria.
These multidrug-resistant bacteria are not limited to hospitals but also occur in a variety of human communities world-wide. In many cases, multidrug-resistant infections can lead to potentially fatal conditions and require hospitalization. A compound having good activity against various bacteria, including multidrug-resistant bacteria such as Staphylococcus sp., Streptococcus sp. and Enterococcus sp., would meet a serious medical need, and also provide health care cost savings by minimizing treatment failures, laboratory testing, and hospitalization6). In our search for new and effective antibiotics, CJ-15,696
and 7 novel analogs (1) (2) (3) (4) (5) (6) (7) (8) were isolated from the fermentation broth of the fungus Cladobotryum varium CL 12284, as new furopyridine type antibiotics7). This paper describes the fermentation, isolation and structure determination of the furopyridine antibiotics and their antibacterial activity. Biotransformation of CJ-15,696 to three novel compounds is also described.
Producing Strain and Fermentation
The producing strain, designated as Cladobotryum varium8) CL12284, was obtained from the New York Botanical Garden (New York, U.S.A.). It was deposited under the accession number FERM BP-5732 to National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology (Tsukuba, Japan).
The fermentation of C. varium was performed in both solid-supported media and liquid media. For the solid supported fermentation, two 500-ml flasks containing 100ml of Medium-1 (potato dextrose broth 2.4%, yeast extract 0.5% and agar 0.1%) were inoculated with vegetative cell suspension from a slant culture of on a rotary shaker with 7-cm throw at 210rpm, to obtain seed cultures. Aliquots (5ml, each) of the seed cultures were used to inoculate thirty 500-ml flasks containing 100ml of Medium-2 (glucose 1%, glycerol 6.6%, NZ Amine Type A 0.5%, ammonium sulfate 0.2%, defatted soybean meal 0.5%, tomato paste 0.5%, sodium citrate 0.2%, adjusted to pH 7.0) and 30g buckwheat. Incubation without shake.
For the liquid fermentation, a 500-ml flask containing Medium-1 (150ml) was inoculated with 5ml of a C. varium seed culture prepared as described above. The flask produce a second seed culture. The second seed culture was used to inoculate a 6-liter fermentation vessel containing 3 liters of sterile medium (Medium-3: glycerol 8.5%, soybean meal 0.5%, corn flour 1.0% and corn steep solid 0.25%, adjusted to pH 5.0). The fermentation was carried out at 3 liters per minute.
Isolation of Furopyridine Antibiotics
Compounds 1-6 were isolated from the solid-supported fermentation of C. varium. The fermentation broth (3 liters) was paper-filtered after stirring with 3 liters of ethanol, overnight. The filtrate was concentrated to an aqueous solution (500ml), applied onto a Diaion HP20
(Mitsubishikasei) column and eluted with 30%, 50% and 100% aqueous methanol followed by acetone. The methanol and acetone fractions were combined, evaporated The molecular formulas of all furopyridines were determined by HR-FAB-MS considering the number of protons and carbons from NMR data ( Table 2) .
Furopyridines 1-8 could be separated into two groups by the UV absorption maxima as described in the Physicochemical Properties section: one is the group comprised of 1, 2, 5 and 6; and the other is comprised of 3, 4, 7 and 8. This suggested the furopyridines in each group have a common chromophore.
Structure Determination of 1, 2, 4, 5 and 6 NMR analysis, including 2D experiments, of compounds 1, 2, 4, 5 and 6 revealed partial structures consisting of a mono-substituted benzene and an aliphatic portion for each structure. However, complete structure elucidation was not possible based on NMR alone, due to undetectable carbon signals on the pyridine ring. Fortunately, the compounds in the former group (1, 2, 5 and 6) were easily crystallized, and their structures were all determined by single crystal X-ray analysis ( Fig. 2 and Table 3 ). These compounds possessed the 2,3-dihydro-4-hydroxy-5-phenylfuropyridine moiety, which is responsible for the UV absorption at 233.0-235.0nm. From the latter group (3, 4, 7, and 8), 4 was the only one succeeded on its crystallization, and the structure was determined by single crystal X-ray analysis ( Fig. 2 and Table 3 ). Compound 4 was found to have a 2,3-dihydro-4-hydroxy-7-phenylfuropyridine moiety, which is responsible for the UV absorption at 245.0-247.0nm.
The 1H and 13C NMR chemical shifts (Table 2) for 1, 2, 4, 5 and 6 were assigned by analysis of 1H-1H COSY, 13C-1H COSY and COLOC spectra.
Structure Determination of 3
The molecular formula of CJ-16,170 (3) was determined to be C19H21NO3. Compared to the molecular formula of 4, 3 has a gain of 2 hydrogens. It is also clear that 3 has the same 2,3-dihydro-4-hydroxy-7-phenylfuropyridine skeleton as that of 4, based on the UV spectrum, 1H and 13C NMR spectra. Further, 1H-1H COSY and COLOC experiments ( of the 2-butenyl group and the relative configuration of C-2 and C-3 were determined by the differential NOE experiments (Fig. 4) . NOEs from H-6' to H-1' and H-3' are consistent with cis-geometry. The same NOEs and, vice versa, a NOE between H-2 and H-5' are consistent with the C-2, 3 configurations. From the above data, the structure of 3 was determined as shown in Fig. 1 .
Structure Determination of 7
The molecular formula of CJ-16,196 (7) was determined to be C19H21NO4. Compared to the molecular formula of 4, 7 has an increase of 2 hydrogens and 1 oxygen. The UV spectrum, 1H and 13C NMR spectra of 7 were very similar to those of 4, suggesting that the 2,3-dihydro-4-hydroxy-7-phenylfuropyridine skeleton was unchanged. In the 1H-1H COSY experiment (Fig. 3) , a large spin system between COLOC experiment (Fig. 3 ), long range couplings from Hsuggested the presence of 3-hydroxy-2-methylbut-1-enyl group as a side chain moiety. The side chain moiety was skeleton by the observation of long range coupling from Hwas also connected to C-3 by the observation of long range 3a. Finally, the C-2 methine carbon of furopyridine must have a hydroxy group because of the chemical shift of C-2 and the molecular formula of 7. The trans-geometry of the olefin was determined by NOEs observed between H-5' and H-3'/H-4' (Fig. 4) . The relative stereochemistry between C-2 and C-3 was also determined as cis-configuration based 5.98) . From all the data above, the structure of 7 was determined as shown in Fig. 1 .
Structure Determination of 8
The molecular formula of CJ-16,197 (8) was identical to that of 7. The 1D and 2D NMR spectra and differential NOE experiments of 8 indicated the same carbon skeleton and relative configuration between C-2 and C-3 as those of The fermentation broths were analyzed by HPLC 1 to 6 days after substrate addition. As a result, Calonectria decora (FERM BP-6124), Cunninghamella echinulata var. elegans (FERM BP-6126), and Actinomyces sp. (FERM BP-6125) were found to produce new furopyridine derivatives that were later isolated from larger scale fermentations and assigned as CP-741,326 (9), CP-473,195
(10) and CP-473,198 (11) . The structures of these biotransformation products were readily deduced as shown in Fig. 1 by the comparisons of molecular formula and 1H NMR (Table 4) to those of 1 and 2 as described below.
CP-471,326 (9) has an additional oxygen compared to 1, and the proton NMR spectrum differs from the spectrum of Thus 9 was produced by hydroxylation at the 4' position.
CP-473,195 (10) also has an additional oxygen compared to 1, and the proton NMR spectrum clearly shows a paracoupled with 8.5Hz) instead of mono-substituted benzene derived from 1 by hydroxylation at the para-position of the benzene ring.
The molecular formula for CP-473,198 (11) indicated that 1 was modified by the addition of two hydrogens and an oxygen atom. The proton NMR spectrum of 11 showed the presence of a hydroxymethyl substituent on C-3 in place of the aldehyde moiety, thus accounting for the addition of the 2 hydrogens. Hydroxylation at C-4' was also revealed by the proton NMR data, and accounted for the addition of oxygen.
Considering the facts that these compounds were simply derived from 1 and the good correspondence of 1H NMR data, the relative stereochemistries of the dihydrofuran ring in 9, 10, and 11 were assumed to be the same as those of 1. 
Discussion
When this work was started, the structure of CJ-15,696
(1)7) had not been reported in the literature. Because of this novel structure and its modest activity against some antibiotic-resistant bacterial pathogens, it was of interest to search for analogs either coproduced with CJ-15,696 or made by microbial biotransformation of it. Unfortunately, none of the analogs discovered had any better antibacterial activity than CJ-15,696. In 1997 and 1998, another group described a compound isolated from Cladobotryum with the same structure as CJ-15,696 which they called Tables 1 and 2 .
Single Crystal X-Ray Analysis Siemens R3RA/v diffractometer. Atomic scattering factors were taken from the International Tables for XRay Crystalloagraphy (Vol. IV, pp. 55, 99, 149). All crystallographic calculations were facilitated by the SHELXTL system (Nicolet Instrument Co., 1981). All diffractometer data were collected at room temperature. A trial structure was obtained by direct methods and this trial structure refined by conventional means. Hydrogen positions were calculated wherever possible. The methyl hydrogens and the hydrogens on oxygen were located by difference Fourier techniques. The hydrogen parameters were added to the structure factor calculations but were not refined. The shifts calculated in the final cycles of least squares refinement were all less than 0.1 of the corresponding standard deviations. A final difference Fourier revealed no missing or misplaced electron density.
Pertinent crystal, data collection, and refinement are summarized in Table 3 , including the final R-index. The refined structure was plotted using the SHELXTL plotting package (Fig. 2) . The absolute configuration was not determined in this analysis because no suitable "heavy atom" was present in the structure. The coordinates, anisotropic temperature factors, distances and angles of each structure were submitted as supplementary material.
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